August 2025 in “JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA” This study reported that a spray containing Origanum marjoram essential oil significantly improved hair regrowth, dermal thickness, weight, and lymphocyte levels in rabbits with cyclophosphamide-induced alopecia, suggesting its potential as a natural alternative for hair loss treatment.
August 2025 in “Galen Medical Journal” In this study, among 2,000 patients with alopecia universalis, mesotherapy combined with systemic treatments like BMI, JAK inhibitors, and adalimumab showed the highest success in hair regrowth, particularly for children, with the combination therapy group achieving a 42% positive response rate.
July 2025 in “Journal of Investigative Dermatology”
This study explored the molecular mechanisms by which Polygonum multiflorum may treat androgenic alopecia, suggesting it influences cell apoptosis and inflammation through specific pathways, with potential application value pending further testing.
This study suggests that while alopecia areata presents similarly across different skin tones, hair loss may be underestimated in individuals with more tightly coiled hair without a comprehensive examination, highlighting the need for culturally sensitive evaluation approaches, particularly for Black women.
June 2025 in “Journal of Ayurveda and Integrated Medical Sciences” In this study, a case of alopecia areata showed significant improvement in scalp health and hair regrowth following Shiropichu therapy, an Ayurvedic technique using coconut oil pads on the scalp, suggesting it as a potential non-invasive treatment option.
April 2025 in “Journal of Pioneering Medical Science” This study concluded that oral and topical minoxidil have similar overall benefits in treating androgenetic alopecia, but topical minoxidil improved hair density more and had fewer adverse effects.
April 2025 in “Journal of Ethnopharmacology” This study elucidated the multi-component and multi-target mechanisms by which TR and Am may provide therapeutic benefits for treating androgenetic alopecia.
January 2025 in “Journal of Bacha Khan Medical College.” This study compared two PRP preparation techniques for treating androgenetic alopecia and found that both methods led to some improvement in hair loss, but further research is suggested due to variations in PRP preparation.
January 2025 in “Case Reports in Dermatological Medicine” This report describes an eight-year-old girl with severe hair shaft abnormalities who showed significant improvement after a single session of adipose tissue–derived exosome therapy, highlighting its potential as an innovative treatment option and the need for further studies to confirm its efficacy and safety.
December 2024 in “Research Square (Research Square)” In this phase I/II clinical trial, placenta-derived mesenchymal stem cell exosome therapy significantly improved hair density and diameter, and reduced hair loss in patients with androgenetic alopecia, though further large-scale studies are needed to confirm these results and investigate the underlying molecular mechanisms.
November 2024 in “Fizioterapevt (Physiotherapist)” This study found that combining fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved the psycho-emotional state and quality of life in patients with diffuse telogen effluvium, performing better than individual treatments alone, as measured by the DIQOL index.
September 2024 in “Research Square (Research Square)” This study found that bi-weekly 1550nm low-level laser therapy significantly improved hair loss conditions and scalp health in participants, suggesting its potential as an effective non-invasive treatment option.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
May 2024 in “Chemical engineering journal” This study reports that a new minoxidil and epigallocatechin gallate co-loaded ionic liquids system showed superior efficacy in promoting hair regrowth in a mouse model of androgenic alopecia by activating hair follicle stem cells and improving microenvironment conditions, compared to existing minoxidil products.
January 2024 in “Tropical Journal of Pharmaceutical Research” This study found that 5% minoxidil liniment was more effective than 2% minoxidil for treating female pattern hair loss over 6 months, with the higher dose showing significant improvement, especially in severe cases.
January 2024 in “International Journal of Dermatology Research” This randomized clinical trial found that both topical ethinylestradiol 0.01% combined with minoxidil 2% and minoxidil 2% alone were similarly effective in enhancing hair growth for female pattern hair loss, though minoxidil alone was better tolerated with fewer side effects over 24 weeks.
January 2024 in “Journal of chemical health risks” In this study, gold nanoparticles-embedded ceria nanoparticles with enhanced antioxidant activities effectively reduced inflammation and colon injury in a colitis mouse model, suggesting their potential as a nano-therapeutic for inflammatory bowel disease.
December 2023 in “Medicine” This study observed that platelet-rich gel for scalp defect reconstruction was more cost-effective and less painful but resulted in poorer hair growth compared to the external tissue expansion technique.
January 2023 in “International Journal of Pharmacy and Pharmaceutical Science” In this observational study conducted in Bengaluru, India, among 272 dermatology patients, the authors reported that dermatitis was the most common condition treated with corticosteroids, with a preference for topical applications; desonide was the most frequently prescribed drug.
January 2022 in “Biocell” This review outlines the potential of mesenchymal stem cells and their derivatives as emerging therapies for atopic dermatitis, but reports no new clinical results; the authors highlight the need for further investigation.
January 2022 in “Frontiers in Medical Science Research” This article discusses the perspectives of Western and Chinese medicine on alopecia areata and proposes that blood stasis may be a key factor, recommending treatments focused on blood circulation.
April 2021 in “HIV & AIDS Review” This study reported that GA 0.1% spray led to only slight improvement in treating anogenital warts among HIV-positive patients over twelve weeks.
November 2020 in “World Journal of Integrated traditional and western Medicine(WJIM)” This study reports on three cases where Shengyang Sanhuo Decoction, a traditional treatment, was used to address alopecia by supporting spleen and stomach health, as theorized to counteract causes like emotional stress and improper diet.
This trial will compare the effectiveness of spironolactone to doxycycline for treating acne in adult females, potentially offering an alternative to antibiotics and isotretinoin.
This trial explores whether spironolactone is more effective than cyclines for treating moderate acne in adult women, providing a potential alternative amidst concerns over antibiotic resistance.
May 2015 in “UC Merced Undergraduate Research Journal” This review suggests that while both pharmaceuticals and behavioral therapies can reduce symptoms of trichotillomania, behavioral therapies often prove more effective, though long-term effectiveness remains uncertain.
January 2012 in “Jounal of The Korean Society of cosmetology” Applying conditioner mid-treatment reduces hair damage during perms.
January 2011 in “Liaoning Zhongyiyao Daxue xuebao” This study found that Chinese medicine treatment "Tonifying Kidney and Removing toxins" significantly improved clinical symptoms and reduced disease activity in patients with systemic lupus erythematosus compared to controls.
November 2006 in “Yafteh” This study found that an herbal drug reduced the duration of telogen effluvium more effectively than minoxidil in patients.